On Wednesday, Dec. 14, 2016 the U.S. Drug Enforcement Administration added a new rule to the Federal Registry classifying marijuana derivatives, including cannabidiol, CBD, as separate entities from marijuana itself, but still under the Schedule I drug – having no medicinal purpose – the same classification as heroin.
Although the distinction of a difference between marijuana and CBD by the DEA was welcomed by proponents of the non-psychoactive naturally-occurring chemical cannabidiol, one of the major chemical components of the plant, along with the psychoactive chemical THC, CBD’s classification as a Schedule I drug on the federal level was not.
The DEA’s ruling on marijuana extracts and/or compounds, including CBD, allows the agency to assign a different identification number to marijuana than to its extracts, allowing the agency to more specifically track both shipments of the extract products and requests for its use in research. Currently, extracts of marijuana are cataloged the under the same identifying number as marijuana itself.
The wording of the new ruling, 21-CFR-Part1308, answers two questions that come immediately to mind: 1.) If CBD is not psychoactive, and it isn’t, why is it being listed along with Schedule I drugs such as heroin and LSD that have no known medicinal purposes and a high potential for abuse? And 2.) If CBD isn’t psychoactive, why does the DEA have any jurisdiction over it?
Here is the explanation in the DEA ruling:
“For practical purposes, all extracts that contain CBD will also contain at least small amounts of other cannabinoids. However, if it were possible to produce from the cannabis plant an extract that contained only CBD and no other cannabinoids, such an extract would fall within the new drug code.”
Temporary safeguards already in place for those patients who use CBD extract in states where medicinal use of marijuana has been legalized will continue to offer protection from the new federal-level ruling, including the Rohrbacher-Farr amendment that prevents the U.S. Department of Justice from spending money to interfere with state medical marijuana laws.
Freelance writer of 15+ years who is passionate about writing. Liberal Arts and Social Sciences background. Avid reader.Thirty-plus years experience as a registered nurse. Have lived in various parts of the United States, including a recent seven-year stint in Oklahoma City and back home now in Ohio. Writes about U.S. News, Health and Politics for The Daily Voice News. Contact me at [email protected]